
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Nov 04, 2025 02:15 am UTC| Business Health Law
Pfizer has filed a second lawsuit against Danish pharmaceutical giant Novo Nordisk, accusing the company of deliberately stalling its $9 billion bid for biotech firm Metsera to hinder competition in the booming obesity...

Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Nov 01, 2025 10:43 am UTC| Politics Governance Health Economy
Americans preparing to enroll in 2026 Affordable Care Act (ACA) health insurance plans are facing steep premium hikes, with monthly costs expected to more than double on average. The sharp rise stems from the expiration of...

Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Oct 31, 2025 06:54 am UTC| Business Health
Eli Lilly announced that its experimental weight-loss pill, orforglipron, meets most of the criteria for the U.S. Food and Drug Administrations (FDA) new national priority voucher, positioning it for potentially...

Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Oct 26, 2025 23:29 pm UTC| Business Health
Swiss pharmaceutical giant Novartis has announced a definitive agreement to acquire U.S.-based biotech firm Avidity Biosciences for approximately $12 billion in cash, marking another major step in its expansion into the...

Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Oct 19, 2025 00:59 am UTC| Business Health Politics
Novo Nordisk has named U.S. pharmaceutical executive Greg Miley as its new Global Head of Corporate Affairs, a strategic move as the Danish drugmaker faces heightened scrutiny from U.S. President Donald Trump over drug...

Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Oct 18, 2025 02:34 am UTC| Business Health Politics
Novo Nordisk has named U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, a move aimed at strengthening its political and public relations strategy as President Donald Trump intensifies pressure...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Oct 17, 2025 01:07 am UTC| Politics Business Health Science Economy
U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...